PDCD1 and neoplasm: To characterize changes in the tumor microenvironment associated with the synergistic antitumor activity of AA and anti-PD1, we performed immunofluorescence for markers of immune cell infiltration and function and quantified the staining with artificial intelligence (AI) technology.